Intracorporeal papaverine injection in androgen deprived men

H. W. Gilbert, D. A. Gillatt, K. M. Desai, J. C. Gingell

Research output: Contribution to journalArticle

Abstract

The intracorporeal injection of papaverine (ICP) is now a well recognized therapeutic option in the management of impotence. The current treatment of advanced prostatic carcinoma causes erectile failure. Although intracorporeal papaverine can induce erections in these men, libido is also reduced so that the role of ICP is limited to those men complying with the wishes of a highly motivated partner.

Original languageEnglish
Pages (from-to)161
Number of pages1
JournalJournal of the Royal Society of Medicine
Volume83
Issue number3
Publication statusPublished - 1990
Externally publishedYes

    Fingerprint

Cite this